Cargando…
Contrast-enhanced mammography-guided biopsy: technique and initial outcomes
Contrast-enhanced mammography-guided biopsy (CEM-Bx), a novel technique for diagnosing suspicious enhanced lesions, was commercialized for clinical application in 2021; however, there are only a few publications documenting this technique in the existing literature. The aim of this study was to eval...
Autores principales: | Tang, Ya-Chun, Cheung, Yun-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423379/ https://www.ncbi.nlm.nih.gov/pubmed/37581028 http://dx.doi.org/10.21037/qims-23-137 |
Ejemplares similares
-
A case report of breast cancer in silicone-injected breasts diagnosed by an emerging technique of contrast-enhanced mammography-guided biopsy
por: Cheung, Yun-Chung, et al.
Publicado: (2022) -
Contrast-enhanced mammography-guided biopsy: technical feasibility and first outcomes
por: Alcantara, R., et al.
Publicado: (2022) -
Contrast-enhanced spectral mammography (CESM)-guided breast biopsy as an alternative to MRI-guided biopsy
por: James, Jonathan
Publicado: (2022) -
Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
por: Liew, Amanda Ling Fung, et al.
Publicado: (2022) -
Preoperative assessment of contrast-enhanced spectral mammography of diagnosed breast cancers after sonographic biopsy: Correlation to contrast-enhanced magnetic resonance imaging and 5-year postoperative follow-up
por: Cheung, Yun-Chung, et al.
Publicado: (2020)